Novartis Returns to Growth on Sales Momentum From Key Drugs

Date:




Second-quarter net sales rose 1% at constant currency as growth from some of its top-selling products offset declines for medicines that lost patent protection.



Source link

Share post:

Subscribe

spot_imgspot_img

Popular

More like this
Related